Get the Stockscreener App
10.00
1.57%
-0.16
After Hours:
10.05
0.05
+0.50%
Evolent Health Inc stock is traded at $10.00, with a volume of 2.55M.
It is down -1.57% in the last 24 hours and down -8.00% over the past month.
Evolent Health Inc is engaged in healthcare delivery and payment. The company supports health systems and physician organizations in their migration toward value-based care and population health management. It provides specialty care management services in oncology, cardiology, musculoskeletal markets and holistic total cost of care management along with an integrated platform for health plan administration and value-based business infrastructure under one go to market package. The primary solutions provided by the company include specialty care management services, total cost of care management, and administrative services.
See More
Previous Close:
$10.16
Open:
$10.3
24h Volume:
2.55M
Relative Volume:
0.96
Market Cap:
$1.15B
Revenue:
$2.35B
Net Income/Loss:
$-74.42M
P/E Ratio:
-10.64
EPS:
-0.94
Net Cash Flow:
$150.93M
1W Performance:
-20.26%
1M Performance:
-8.00%
6M Performance:
-52.04%
1Y Performance:
-67.27%
1-Day Range:
$9.96
$10.47
1-Week Range:
$9.88
$12.78
52-Week Range:
$9.88
$35.00
Evolent Health Inc Stock (EVH) Company Profile
Name
Evolent Health Inc
Sector
Industry
Phone
571-389-6000
Address
800 NORTH GLEBE RD, SUITE 500, ARLINGTON
Compare EVH with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
EVH
Evolent Health Inc
|
10.00 | 1.15B | 2.35B | -74.42M | 150.93M | -0.94 |
|
VEEV
Veeva Systems Inc
|
216.59 | 35.16B | 2.66B | 665.91M | 1.08B | 4.05 |
|
SOLV
Solventum Corp
|
73.51 | 12.70B | 8.26B | 66.00M | 1.17B | 0.3682 |
|
DOCS
Doximity Inc
|
53.72 | 10.03B | 516.85M | 174.11M | 217.38M | 0.87 |
|
HQY
Healthequity Inc
|
102.42 | 8.88B | 1.15B | 96.70M | -161.99M | 1.09 |
|
WAY
Waystar Holding Corp
|
37.47 | 6.45B | 906.14M | -52.62M | 89.62M | -0.3621 |
Evolent Health Inc Stock (EVH) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-10-25 | Initiated | Needham | Buy |
| Dec-03-24 | Reiterated | BTIG Research | Buy |
| Nov-08-24 | Downgrade | Stephens | Overweight → Equal-Weight |
| Oct-11-24 | Initiated | KeyBanc Capital Markets | Overweight |
| Aug-09-24 | Upgrade | Truist | Hold → Buy |
| Apr-22-24 | Initiated | Citigroup | Buy |
| Mar-01-24 | Initiated | Oppenheimer | Outperform |
| Jan-03-24 | Initiated | Barclays | Overweight |
| Dec-06-23 | Initiated | JMP Securities | Mkt Outperform |
| Oct-16-23 | Initiated | UBS | Buy |
| Apr-12-23 | Initiated | Stephens | Overweight |
| Nov-01-22 | Initiated | Truist | Hold |
| Jul-29-22 | Initiated | RBC Capital Mkts | Outperform |
| Mar-30-22 | Initiated | Guggenheim | Buy |
| Nov-18-21 | Upgrade | JP Morgan | Neutral → Overweight |
| Apr-29-21 | Resumed | JP Morgan | Neutral |
| Jan-07-21 | Initiated | BTIG Research | Buy |
| Jul-06-20 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Jun-05-20 | Downgrade | Goldman | Buy → Neutral |
| Jun-02-20 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| Oct-05-18 | Resumed | Leerink Partners | Outperform |
| Jun-04-18 | Initiated | Piper Jaffray | Overweight |
| Apr-24-18 | Resumed | JP Morgan | Neutral |
| Sep-20-17 | Initiated | KeyBanc Capital Mkts | Overweight |
| Jun-02-17 | Initiated | Robert W. Baird | Outperform |
| Mar-14-17 | Initiated | Oppenheimer | Outperform |
| Jan-13-17 | Upgrade | Wells Fargo | Market Perform → Outperform |
| Oct-28-16 | Resumed | JP Morgan | Overweight |
| Aug-05-16 | Reiterated | FBR Capital | Outperform |
| Jul-26-16 | Initiated | Jefferies | Buy |
| Jul-13-16 | Reiterated | FBR Capital | Outperform |
| Mar-29-16 | Initiated | FBR Capital | Outperform |
| Jan-06-16 | Initiated | Canaccord Genuity | Buy |
| Jun-30-15 | Initiated | Goldman | Buy |
| Jun-30-15 | Initiated | JP Morgan | Overweight |
| Jun-30-15 | Initiated | Leerink Partners | Outperform |
| Jun-30-15 | Initiated | Sun Trust Rbsn Humphrey | Buy |
View All
Evolent Health Inc Stock (EVH) Latest News
Evolent Health (NYSE:EVH) Sees Unusually-High Trading VolumeTime to Buy? - MarketBeat
Evolent Health (NYSE:EVH) Price Target Lowered to $14.00 at UBS Group - MarketBeat
Evolent Health FY2024 EPS Estimate Boosted by William Blair - Defense World
Evolent Health FY2024 EPS Forecast Lifted by William Blair - MarketBeat
Evolent Health (NYSE:EVH) Reaches New 12-Month LowHere's Why - MarketBeat
Evolent Health Stock Price (NYSE: EVH) Hit 52 Week Lows as Guidance Falls Short - AskTraders
Evolent Health (NYSE:EVH) Shares Down 2% After Analyst Downgrade - Defense World
Evolent Health (NYSE:EVH) Stock Price Down 2% Following Analyst Downgrade - MarketBeat
Evolent Health stock hits 52-week low at $10.52 amid market challenges - Investing.com
What Analysts Are Saying About Evolent Health Stock - Benzinga
Evolent Health (NYSE:EVH) Sees Strong Trading VolumeShould You Buy? - MarketBeat
Evolent Health (NYSE:EVH) Price Target Cut to $17.00 by Analysts at Royal Bank of Canada - MarketBeat
RBC adjusts Evolent Health price target, praises strong re-contracting efforts - Investing.com UK
Evolent Health (FRA:9EH) Change In Receivables : €-17 Mil (TTM As of Sep. 2024) - GuruFocus.com
Evolent Health (NYSE:EVH) Given New $20.00 Price Target at Truist Financial - Defense World
Evolent Health to Present at J.P. Morgan Conference - TipRanks
Salem Investment Counselors Inc. Raises Stake in Evolent Health, Inc. (NYSE:EVH) - MarketBeat
Truist Financial Lowers Evolent Health (NYSE:EVH) Price Target to $20.00 - MarketBeat
Nordea Investment Management AB Grows Stake in Evolent Health, Inc. (NYSE:EVH) - Defense World
Dr. Abeer AbouYabis Scholarship for Future Doctors Inspires Aspiring Physicians to Tackle Healthcare Challenges - GlobeNewswire Inc.
Evolent Health (NYSE:EVH) Coverage Initiated at Needham & Company LLC - Defense World
JMP Securities Lowers Evolent Health (NYSE:EVH) Price Target to $18.00 - Defense World
Citigroup Issues Pessimistic Forecast for Evolent Health (NYSE:EVH) Stock Price - Defense World
Needham initiates Evolent Health stock with Buy rating, says it's undervalued - Investing.com Canada
Evolent Health's SWOT analysis: stock faces headwinds but analysts see long-term value - Investing.com India
Evolent Health's SWOT analysis: stock faces headwinds but analysts see long-term value By Investing.com - Investing.com South Africa
Citigroup Lowers Evolent Health (NYSE:EVH) Price Target to $18.00 - MarketBeat
Evolent Health, Inc. (NYSE:EVH) Shares Acquired by Harbor Capital Advisors Inc. - MarketBeat
JMP Securities Issues Pessimistic Forecast for Evolent Health (NYSE:EVH) Stock Price - MarketBeat
Needham & Company LLC Initiates Coverage on Evolent Health (NYSE:EVH) - MarketBeat
Needham Initiates Coverage of Evolent Health (EVH) with Buy Recommendation - MSN
High Growth Tech Stocks In The United States To Watch - Simply Wall St
We Think Evolent Health (NYSE:EVH) Can Stay On Top Of Its Debt - Simply Wall St
Evolent Health Inc (EVH) Stock Price Up 3.38% on Jan 2 - GuruFocus.com
Evolent Health, Inc. (NYSE:EVH): Are Analysts Optimistic? - Yahoo Finance
Short Interest in Evolent Health, Inc. (NYSE:EVH) Drops By 7.1% - MarketBeat
Citigroup Initiates Coverage of Evolent Health (EVH) with Buy Recommendation - MSN
Evolent Health, Inc. (NYSE:EVH) Receives Average Rating of "Buy" from Analysts - MarketBeat
Geode Capital Management LLC Sells 80,757 Shares of Evolent Health, Inc. (NYSE:EVH) - MarketBeat
Franklin Resources Inc. Boosts Stock Position in Evolent Health, Inc. (NYSE:EVH) - MarketBeat
Evolent Health (NYSE:EVH) Trading 4.9% HigherHere's Why - MarketBeat
Evolent Health, Inc. (NYSE:EVH) Shares Acquired by Barclays PLC - MarketBeat
Evolent to Appoint Dr. Von Nguyen as Incoming Chief Medical Officer - citybiz
Evolent announces Dr. Von Nguyen as incoming Chief Medical Officer, effective January 1 - The Malaysian Reserve
Evolent Health (EVH) Appoints Dr. Von Nguyen as incoming Chief Medical Officer - StreetInsider.com
Hedge Funds Think That Evolent Health, Inc. (EVH) Will Bounce Back Soon - Insider Monkey
Evolent Health stock hits 52-week low at $10.8 amid market challenges - Investing.com Canada
Evolent Health stock hits 52-week low at $10.8 amid market challenges By Investing.com - Investing.com South Africa
Evolent Health's SWOT analysis: growth prospects amid healthcare cost pressures - Investing.com India
Evolent Health secures new $250 million financing By Investing.com - Investing.com Nigeria
Evolent Health Inc Stock (EVH) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.02%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):